2025-04-25 23:29:23 ET
Encompass Health Corporation (EHC)
Q1 2025 Earnings Conference Call
April 25, 2025, 9:00 AM ET
Corporate Participants
Mark Miller - Chief Investor Relations Officer
Mark Tarr - President and Chief Executive Officer
Douglas Coltharp - Executive Vice President and Chief Financial Officer
Conference Call Participants
Pito Chickering - Deutsche Bank
Whit Mayo - Leerink Partners
Matthew Gillmor - KeyBanc Capital Markets
Ann Hynes - Mizuho Securities
Joanna Gajuk - BofA Securities
Brian Tanquilut - Jefferies
A.J. Rice - UBS
Jared Haase - William Blair
Andrew Mok - Barclays
John Ransom - Raymond James
Presentation
Operator
Good morning, everyone, and welcome to Encompass Health's First Quarter 2025 Earnings Conference Call. At this time, I'd like to inform all participants that their lines will be in a listen-only mode. After the speakers' remarks, there will be a question-and-answer period. [Operator Instructions] Today's conference call is being recorded. If you have any objections to potentially being recorded, you may disconnect at this time.
I will now turn the call over to Mark Miller, Encompass Health's Chief Investor Relations Officer.
Mark Miller
Thank you, operator, and good morning, everyone. Thank you for joining Encompass Health's First Quarter 2025 Earnings Call. Before we begin, if you do not already have a copy, the first quarter earnings release, supplemental information and related Form 8-K filed with the SEC are available on our website at encompasshealth.com.
On Page 2 of the supplemental information, you will find the Safe Harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements, such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control.
Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt and cost trends that could cause actual results to differ materially from our projections, estimates and expectations are discussed in the company's SEC filings, including the earnings release and related Form 8-K, the Form 10-K for the year ended December 31, 2024, and the Form 10-Q for the quarter ended March 31, 2025, when filed. We encourage you to read them....
Read the full article on Seeking Alpha
For further details see:
Encompass Health Corporation (EHC) Q1 2025 Earnings Call Transcript
